Cabigon, Christen .

HRN: 28-54-86  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/16/2026
CO-AMOXICLAV 625MG (TAB)
03/16/2026
03/22/2026
ORAL
625mg
BID
PROM
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines